Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Spotlight on NK1 antagonists

Nov. 1, 1996

No Comments

New method of total synthesis of epibatidine reported

Nov. 1, 1996

No Comments

Lanepitant in clinical trials for pain

Nov. 1, 1996

No Comments

Dong-A's analgesic drug candidate in clinical trials

Nov. 1, 1996

No Comments

Glaxo Wellcome anesthetic receives European clearance

Oct. 25, 1996

No Comments

Novel antimigraine agent launched in the U.K.

Oct. 25, 1996

No Comments

Antimigraine agents with affinity for 5-HT receptors reported by Pierre Fabre

Oct. 25, 1996

No Comments

Anesta's Actiq on schedule for launch

Oct. 25, 1996

No Comments

Neurex broadens clinical program for SNX-111

Oct. 25, 1996

No Comments

Steroid does not adequately improve symptoms of chronic fatigue syndrome

Oct. 25, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Neurology/psychiatric
RSS

Spotlight on NK1 antagonists

New method of total synthesis of epibatidine reported

Lanepitant in clinical trials for pain

Dong-A's analgesic drug candidate in clinical trials

Glaxo Wellcome anesthetic receives European clearance

Novel antimigraine agent launched in the U.K.

Antimigraine agents with affinity for 5-HT receptors reported by Pierre Fabre

Anesta's Actiq on schedule for launch

Neurex broadens clinical program for SNX-111

Steroid does not adequately improve symptoms of chronic fatigue syndrome

Today's news in brief

Today's news in brief

In muscular dystrophies, gene therapies race the clock

Bridgebio, with FDA approval, faces Pfizer in ATTR

Apollo signs near-$1B deal for Sunshine’s FGF21/GLP-1 injection

Neurology/psychiatric RSS

Neurology/psychiatric
RSS